Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 77.029
Filtrar
1.
Hematol Oncol Clin North Am ; 38(1): 229-238, 2024 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-37516631

RESUMEN

Although current value frameworks and economic models have allowed us to better quantify the net benefit associated with cancer therapy, holistic cancer care must consider patient time, family and social values, and overall life expectancy. Training programs must include training in health services research, difficult conversations, and shared decision-making strategies that are developed in social and cultural frameworks for their settings.


Asunto(s)
Países en Desarrollo , Neoplasias , Humanos , Neoplasias/terapia
2.
Hematol Oncol Clin North Am ; 38(1): 35-53, 2024 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-37597998

RESUMEN

Central America and the Caribbean is a highly heterogeneous region comprising more than 30 countries and territories with more than 200 million inhabitants. Although recent advances in the region have improved access to cancer care, there are still many disparities and barriers for obtaining high-quality cancer treatments, particularly for those from disadvantaged populations, immigrants, and rural areas. In this article, we provide an overview of cancer care in Central America and the Caribbean, with selected examples of issues related to disparities in access to care and suggest solutions and strategies to move forward.


Asunto(s)
Disparidades en Atención de Salud , Neoplasias , Humanos , Región del Caribe/epidemiología , América Central/epidemiología , Neoplasias/epidemiología , Neoplasias/terapia
3.
Hematol Oncol Clin North Am ; 38(1): 1-12, 2024 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-37673697

RESUMEN

Inequity exists along the continuum of cancer and cancer care delivery in the United States. Marginalized populations have later stage cancer at diagnosis, decreased likelihood of receiving cancer-directed care, and worse outcomes from treatment. These inequities are driven by historical, structural, systemic, interpersonal, and internalized factors that influence cancer across the pathologic and clinical continuum. To ensure equity in cancer care, interventions are needed at the level of policy, care delivery, interpersonal communication, diversity within the clinical workforce, and clinical trial accessibility and design.


Asunto(s)
Atención a la Salud , Neoplasias , Embarazo , Femenino , Niño , Recién Nacido , Humanos , Estados Unidos/epidemiología , Atención Perinatal , Neoplasias/epidemiología , Neoplasias/terapia
4.
Crit Rev Eukaryot Gene Expr ; 34(1): 1-13, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-37824388

RESUMEN

Destruction of the tumor (cancerous) cells may be caused by live viruses, which have replicative ability and replicate selectively in tumor cells, known as oncolytic virotherapy. In comparison of conservative cancer therapy, tumor-selective replicating viruses have more advantages. These viruses have introduced new methodologies for the human cancer treatment. Numerous strategies are used in development of virotherapeutics. Virotherapy is not unusual concept, but modern advances in technology of genetic modification of oncolytic viruses have improved the ability of targeting tumor cells more specifically, it triggered the development of novel ammunition to fight cancer. An effective virotherapeutic approach with oncolytic viruses exhibits the feasibility and safety under clinical approach. New strategies are being explored to overcome basic obstacles and challenges in virotherapy. Administration of oncolytic viruses, logically, will successfully augment new treatments against many kinds of tumors. Some encouraging antitumor responses shown by combination therapy are provoking strong immunity against established cancer. Chief developments in oncolytic virotherapy have seen in past several years. Significant understandings have been provided by findings on the interface among immune comebacks and viruses, whereas potential results have shown in clinical trials.


Asunto(s)
Neoplasias , Viroterapia Oncolítica , Virus Oncolíticos , Humanos , Viroterapia Oncolítica/métodos , Neoplasias/terapia , Virus Oncolíticos/genética , Terapia Combinada
5.
Curr Drug Deliv ; 21(3): 403-420, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-37143265

RESUMEN

The surface proteins on cell membranes enable the cells to have different properties, such as high biocompatibility, surface modifiability, and homologous targeting ability. Cell-membrane-derived vesicles have features identical to those of their parental cells, which makes them one of the most promising materials for drug delivery. Recently, as a result of the impressive effects of immunotherapy in cancer treatment, an increasing number of researchers have used cell-membrane-derived vesicles to enhance immune responses. To be more specific, the membrane vesicles derived from immune cells, tumor cells, bacteria, or engineered cells have the antigen presentation capacity and can trigger strong anti-tumor effects of the immune system. In this review, we first indicated a brief description of the vesicles and then introduced the detection technology and drug-loading methods for them. Secondly, we concluded the characteristics and applications of vesicles derived from different sources in cancer immunotherapy.


Asunto(s)
Neoplasias , Humanos , Neoplasias/terapia , Sistemas de Liberación de Medicamentos , Bacterias , Inmunoterapia/métodos
6.
Pediatr Blood Cancer ; 71(1): e30710, 2024 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-37828816

RESUMEN

BACKGROUND/OBJECTIVE: The use of patient-reported outcomes (PRO) is increasing in pediatric clinical practice and research, including in clinical trials. Treatment teams are now able to discern differences in symptom and function reports between children with cancer and their family caregivers. Few studies, however, have quantified such differences. DESIGN/METHODS: Children and caregivers were matched to create a dyad sample, and child/caregiver agreement of responses to the Patient-Reported Outcome Measurement Information System (PROMIS) Pediatric symptom and function measures were examined using the established minimally important difference (MID) value (three points) derived from these measures. Latent class analysis (LCA) was then used to analyze the status/patterns of response agreement. RESULTS: A total of 430 dyadic cases (dyads) were used for LCA modeling. Three classes of child-caregiver concordance resulted: (a) Agreement-caregiver and child within one MID (200 dyads); (b) Disagreement-caregiver underestimating symptoms (47 dyads with caregiver scores more than 1 MID lower than the child scores); and (c) Disagreement-caregiver overestimating symptoms (183 dyads with caregiver scores more than 1 MID higher than child scores). CONCLUSION: As PRO use increases in pediatric oncology, clinician identification of child/caregiver differences on symptom and function reports will help to distinguish family perceptions of cancer treatment impact. The treatment goal, in addition to mitigating symptom and function treatment-related burdens for the child and caregiver, may now also be to discern the direction and clinical meaning of the difference within the child-parent dyad.


Asunto(s)
Cuidadores , Neoplasias , Humanos , Niño , Oncología Médica , Neoplasias/terapia , Medición de Resultados Informados por el Paciente
7.
J Surg Res ; 293: 389-395, 2024 01.
Artículo en Inglés | MEDLINE | ID: mdl-37806226

RESUMEN

INTRODUCTION: Despite advances in cancer treatment, the quality of life (QOL) of survivors varies significantly. We assessed the correlation between socioeconomic factors and long-term QOL in a global cohort of cancer survivors. MATERIALS AND METHODS: Patients were offered surveys via online support groups. Using the Short Form-12 validated questionnaire, physical QOL (PQOL) and mental QOL (MQOL) well-being were compared to the general population. Socioeconomic factors were assessed with regression analysis for impact on QOL. RESULTS: Seven hundred eighty two survivors from six continents responded. They were 57 ± 13 y and 68% female, 90.8% White, with 43 distinct cancer diagnoses. All survivors had PQOL and MQOL scores lower than the general population. Lower education level, household income, and non-White race all correlated with reduced PQOL and/or MQOL. Age was negatively correlated with PQOL (r = -0.08, P = 0.03) and positively correlated with MQOL (r = 0.142, P < 0.001). Care at large regional/academic centers was associated with higher MQOL (42 ± 14 versus 38 ± 11, P = 0.005). Age (ß = -0.1, P = 0.04), education (ß = 1.1, P = 0.005), and income (ß = 2.0, P < 0.001) were predictors of PQOL, while age (ß = 0.2, P < 0.001), income (ß = 1.7, P = 0.002), and community hospital care (ß = -3.6, P = 0.013) were predictors of MQOL. CONCLUSIONS: In a large international survey of cancer survivors, we identified socioeconomic factors and their associations with QOL. Further work should be directed to provide durable support across all socioeconomic classes.


Asunto(s)
Supervivientes de Cáncer , Neoplasias , Humanos , Femenino , Masculino , Calidad de Vida , Factores Socioeconómicos , Encuestas y Cuestionarios , Renta , Neoplasias/terapia
8.
Pediatr Blood Cancer ; 71(1): e30747, 2024 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-37880841

RESUMEN

There are inequitable health outcomes for Aboriginal children with cancer. A quality improvement audit performed at our institution through interviews with families and healthcare workers has highlighted individual, systematic and cultural barriers to equitable and culturally safe healthcare for Aboriginal patients, in addition to facilitators and recommendations for improvements.


Asunto(s)
Neoplasias , Niño , Humanos , Atención a la Salud , Personal de Salud , Neoplasias/terapia , Aborigenas Australianos e Isleños del Estrecho de Torres , Mejoramiento de la Calidad , Auditoría Clínica
9.
Pediatr Blood Cancer ; 71(1): e30753, 2024 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-37899699

RESUMEN

For children with cancer, blood product transfusions are crucial, but can be complicated by transfusion reactions. To prevent these complications, premedication is often given, although not always evidence-based. Herein, we describe a significant decrease in the use of premedication (72%-28%) at our institution after the implementation of standardized guidelines, without an increase in transfusion reactions (3.2% prior vs. 1.5% after standardization). Importantly, there were no severe transfusion reactions leading to hospitalization or death. Our results provide evidence in favor of more judicious use of premedication prior to transfusions in patients 21 years and younger being treated for cancer.


Asunto(s)
Neoplasias , Reacción a la Transfusión , Niño , Humanos , Mejoramiento de la Calidad , Transfusión Sanguínea , Neoplasias/terapia , Premedicación
10.
Pediatr Blood Cancer ; 71(1): e30709, 2024 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-37817346

RESUMEN

BACKGROUND: Despite the challenges that caring for a child with cancer brings for parents, little knowledge is available concerning the effects on the parents' couple relationship. Furthermore, few interventions have been designed to support parents in their couple relationship. The aim of this paper was, therefore, to explore parents' experiences of their couple relationship while having a dependent child with cancer and the support they received from a family-based intervention, the Family Talk Intervention (FTI). METHODS: Data for this paper were taken from semi-structured interviews performed in a pilot study of the FTI in the context of pediatric oncology. In total, 22 couples were interviewed after participating in the FTI. The interviews were transcribed and analyzed using qualitative content analysis. RESULTS: Parents described how maintaining a couple relationship while living with childhood cancer could be very challenging and was not given the highest priority. The FTI was considered a way of providing important support to the couple and a chance for them to sit down together and listen to each other's perspectives on the situation. Parents described that the FTI had helped them gain an increased mutual understanding, sometimes also helping them to realize that they needed more extensive professional support in their relationship. CONCLUSIONS: Living with childhood cancer and upholding a healthy couple relationship is challenging for parents. The FTI has the potential to support couples, mainly by providing opportunities for parents to communicate with each other. However, some couples may be in need of a tailored clinical intervention.


Asunto(s)
Neoplasias , Responsabilidad Parental , Humanos , Niño , Proyectos Piloto , Padres , Neoplasias/terapia , Oncología Médica , Investigación Cualitativa
11.
Hematol Oncol Clin North Am ; 38(1): 55-76, 2024 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-37353378

RESUMEN

Cancer is a major public health problem in South America. The cancer mortality burden is increasing in the region due to its presentation at later stages, which is related to limited access to cancer care. This results in a noticeable inequity in provisions of cancer care including specialized screening programs, as well as cancer-related treatments such as personalized medicine, radiation therapy, palliative care, and survivorship services. Consequently, South America faces many challenges for cancer control, most of them deriving from a lack of funding and unequal distribution of resources and cancer services, affecting mostly the underserved populations in the region.


Asunto(s)
Atención a la Salud , Neoplasias , Humanos , América del Sur/epidemiología , Neoplasias/diagnóstico , Neoplasias/epidemiología , Neoplasias/terapia , Cuidados Paliativos
12.
Hematol Oncol Clin North Am ; 38(1): 77-85, 2024 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-37429789

RESUMEN

The resilience of the system in most specialized oncological institutions in Ukraine should be acknowledged, as well as the level of provision of high-quality special care quickly recovered in the center and areas close to a war zone. This situation has undoubtedly impacted global cancer research progress, as Ukraine is an important venue for many cancer trials.


Asunto(s)
Neoplasias , Humanos , Ucrania/epidemiología , Neoplasias/epidemiología , Neoplasias/terapia , Oncología Médica
13.
J Colloid Interface Sci ; 654(Pt A): 212-223, 2024 Jan 15.
Artículo en Inglés | MEDLINE | ID: mdl-37839238

RESUMEN

The weak catalytic activity of nanocatalysts and the insufficient endogenous hydrogen peroxide (H2O2) in tumor microenvironment (TME) seriously restricted the efficacy of catalytic therapy, and the non-degradability of inorganic nanocarriers was also unfavorable for their clinical applications. Herein, by depositing gold nanoparticles (AuNPs) and platinum nanoparticles (PtNPs) with ultrasmall size and modifying photosensitizer (IR808), a biocompatible bovine serum albumin (BSA) nanoplatform (BSA@Au/Pt-IR808) with triple-amplification of enzyme activity was constructed to enhance photodynamic therapy (PDT) and catalytic therapy. Ultrasmall AuNPs possessed glucose oxidase (GOx)-like activity, by which the self-supplying H2O2 accelerated the dual-enzyme activity of peroxidase (POD) and catalase (CAT) of ultrasmall PtNPs, promoting the generation of hydroxyl radical (·OH) and singlet oxygen (1O2). Compared with BSA-IR808 and BSA@Pt, the yields of 1O2 and ·OH of BSA@Au/Pt-IR808 increased by 38.2% and 18.6%. Under the combination action of photothermal therapy (PTT)/PDT/catalytic therapy of BSA@Au/Pt-IR808, the cell viability significantly reduced to 12.8%, and the tumors were completely eliminated, demonstrating the enhanced PDT and catalytic therapy against breast cancer.


Asunto(s)
Nanopartículas del Metal , Nanosferas , Neoplasias , Fotoquimioterapia , Humanos , Catalasa , Línea Celular Tumoral , Glucosa , Glucosa Oxidasa , Oro/farmacología , Peróxido de Hidrógeno , Nanopartículas del Metal/uso terapéutico , Neoplasias/terapia , Peroxidasa , Platino (Metal)/farmacología , Albúmina Sérica Bovina , Microambiente Tumoral
14.
Clin. transl. oncol. (Print) ; 25(12): 3479-3491, dec. 2023.
Artículo en Inglés | IBECS | ID: ibc-227293

RESUMEN

Introduction Cancer patients often suffer from malnutrition and early detection and raising awareness of nutritional issues is crucial in this population. Methods The Spanish Oncology Society (SEOM) conducted the Quasar_SEOM study to investigate the current impact of the Anorexia–Cachexia Syndrome (ACS). The study employed questionnaires and the Delphi method to gather input from both cancer patients and oncologists on key issues related to early detection and treatment of ACS. A total of 134 patients and 34 medical oncologists were surveyed about their experiences with ACS. The Delphi methodology was used to evaluate oncologists' perspectives of ACS management, ultimately leading to a consensus on the most critical issues. Results Despite widespread acknowledgement of malnutrition in cancer as a significant issue by 94% of oncologists, the study revealed deficiencies in knowledge and protocol implementation. A mere 65% of physicians reported being trained to identify and treat these patients, with 53% failing to address ACS in a timely manner, 30% not monitoring weight, and 59% not adhering to any clinical guidelines. The lack of experience was identified as the primary hindrance to the use of orexigens in 18% of cases. Furthermore, patients reported concerns and a perception of inadequate attention to malnutrition-related issues from their physicians. Conclusion The results of this study point to a gap in the care of this syndrome and a need to improve education and follow-up of cancer patients with anorexia-cachexia (AU)


Asunto(s)
Humanos , Desnutrición/etiología , Desnutrición/terapia , Neoplasias/complicaciones , Neoplasias/terapia , Oncólogos , Anorexia/etiología , Anorexia/terapia , Caquexia/etiología , Caquexia/terapia , Detección Precoz del Cáncer , Encuestas y Cuestionarios , Síndrome
15.
Rev. esp. cir. ortop. traumatol. (Ed. impr.) ; 67(6): 560-575, Nov-Dic. 2023. tab, ilus
Artículo en Español | IBECS | ID: ibc-227631

RESUMEN

La resección en bloque de metástasis en columna vertebral ha sido objeto de estudio en la literatura médica debido a su impacto en la calidad de vida de los pacientes y su efectividad en el control local de la enfermedad. Este análisis bibliográfico examina los hallazgos y perspectivas de estudios publicados en relación con la resección en bloque de oligometástasis vertebrales. La técnica, que implica la extirpación completa del tumor junto con una porción del hueso circundante, ha demostrado mejorar el control local del tumor, reducir la recurrencia y potencialmente prolongar la supervivencia de los pacientes en comparación con las técnicas convencionales de descompresión y estabilización. Sin embargo, la resección en bloque también presenta riesgos y complicaciones, como la morbilidad quirúrgica y el mayor tiempo de recuperación. La selección adecuada de pacientes, la planificación preoperatoria y el enfoque multidisciplinario son fundamentales para optimizar los resultados. A medida que se desarrollan nuevas técnicas y avances en el tratamiento adyuvante, la resección en bloque de oligometástasis vertebrales sigue siendo un área de interés en la investigación oncológica.(AU)


En bloc resection of vertebral metastases has been the subject of study in medical literature due to its impact on patients’ quality of life and effectiveness in local disease control. This bibliographic analysis examines the findings and perspectives of published studies concerning en bloc resection of oligometastases in the spine. The technique, which involves the complete removal of the tumour along with a portion of the surrounding bone, has been shown to improve local tumour control, reduce recurrence, and potentially prolong patient survival compared to conventional decompression and stabilization techniques. However, en bloc resection also presents risks and complications, such as surgical morbidity and extended recovery time. Appropriate patient selection, preoperative planning, and a multidisciplinary approach are essential to optimize outcomes. As new techniques and advances in adjuvant treatment develop, en bloc resection of oligometastases in the spine remains an area of interest in oncological research.(AU)


Asunto(s)
Humanos , Masculino , Femenino , Neoplasias de la Columna Vertebral/terapia , Neoplasias Óseas/terapia , Calidad de Vida , Radioterapia , Quimioterapia , Procedimientos Quirúrgicos Operativos , Traumatología , Procedimientos Ortopédicos , Ortopedia , Columna Vertebral , Neoplasias/terapia , Terapéutica , Neoplasias de la Columna Vertebral/cirugía
16.
Rev. esp. cir. ortop. traumatol. (Ed. impr.) ; 67(6): S560-S575, Nov-Dic. 2023. tab, ilus
Artículo en Inglés | IBECS | ID: ibc-227632

RESUMEN

La resección en bloque de metástasis en columna vertebral ha sido objeto de estudio en la literatura médica debido a su impacto en la calidad de vida de los pacientes y su efectividad en el control local de la enfermedad. Este análisis bibliográfico examina los hallazgos y perspectivas de estudios publicados en relación con la resección en bloque de oligometástasis vertebrales. La técnica, que implica la extirpación completa del tumor junto con una porción del hueso circundante, ha demostrado mejorar el control local del tumor, reducir la recurrencia y potencialmente prolongar la supervivencia de los pacientes en comparación con las técnicas convencionales de descompresión y estabilización. Sin embargo, la resección en bloque también presenta riesgos y complicaciones, como la morbilidad quirúrgica y el mayor tiempo de recuperación. La selección adecuada de pacientes, la planificación preoperatoria y el enfoque multidisciplinario son fundamentales para optimizar los resultados. A medida que se desarrollan nuevas técnicas y avances en el tratamiento adyuvante, la resección en bloque de oligometástasis vertebrales sigue siendo un área de interés en la investigación oncológica.(AU)


En bloc resection of vertebral metastases has been the subject of study in medical literature due to its impact on patients’ quality of life and effectiveness in local disease control. This bibliographic analysis examines the findings and perspectives of published studies concerning en bloc resection of oligometastases in the spine. The technique, which involves the complete removal of the tumour along with a portion of the surrounding bone, has been shown to improve local tumour control, reduce recurrence, and potentially prolong patient survival compared to conventional decompression and stabilization techniques. However, en bloc resection also presents risks and complications, such as surgical morbidity and extended recovery time. Appropriate patient selection, preoperative planning, and a multidisciplinary approach are essential to optimize outcomes. As new techniques and advances in adjuvant treatment develop, en bloc resection of oligometastases in the spine remains an area of interest in oncological research.(AU)


Asunto(s)
Humanos , Masculino , Femenino , Neoplasias de la Columna Vertebral/terapia , Neoplasias Óseas/terapia , Calidad de Vida , Radioterapia , Quimioterapia , Procedimientos Quirúrgicos Operativos , Traumatología , Procedimientos Ortopédicos , Ortopedia , Columna Vertebral , Neoplasias/terapia , Terapéutica , Neoplasias de la Columna Vertebral/cirugía
17.
Curr Sports Med Rep ; 22(11): 380-386, 2023 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-37921391

RESUMEN

ABSTRACT: There is a gap in the literature on the best treatment of clinical sequelae within adolescent and young adult pediatric cancer populations. Children, adolescents, and young adults are at risk for a multitude of immediate and late effects of their disease and treatment that warrant a comprehensive, multidisciplinary team approach to optimize care. Sports medicine providers are well-equipped with their background to join the oncology rehabilitation team in diagnosing and managing cancer-related impairments to help these populations live a healthier and more active lifestyle. In this manuscript, four essential clinical components to consider when returning children, adolescents, and young adults with cancer history to physical activity are discussed: chemotherapy-induced peripheral neuropathy, cardiotoxicity, nutritional deficiencies, and deconditioning.


Asunto(s)
Neoplasias , Adolescente , Niño , Humanos , Adulto Joven , Neoplasias/diagnóstico , Neoplasias/terapia , Ejercicio Físico , Estilo de Vida
18.
Radiol Imaging Cancer ; 5(6): e220153, 2023 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-37921555

RESUMEN

Ongoing discoveries in cancer genomics and epigenomics have revolutionized clinical oncology and precision health care. This knowledge provides unprecedented insights into tumor biology and heterogeneity within a single tumor, among primary and metastatic lesions, and among patients with the same histologic type of cancer. Large-scale genomic sequencing studies also sparked the development of new tumor classifications, biomarkers, and targeted therapies. Because of the central role of imaging in cancer diagnosis and therapy, radiologists need to be familiar with the basic concepts of genomics, which are now becoming the new norm in oncologic clinical practice. By incorporating these concepts into clinical practice, radiologists can make their imaging interpretations more meaningful and specific, facilitate multidisciplinary clinical dialogue and interventions, and provide better patient-centric care. This review article highlights basic concepts of genomics and epigenomics, reviews the most common genetic alterations in cancer, and discusses the implications of these concepts on imaging by organ system in a case-based manner. This information will help stimulate new innovations in imaging research, accelerate the development and validation of new imaging biomarkers, and motivate efforts to bring new molecular and functional imaging methods to clinical radiology. Keywords: Oncology, Cancer Genomics, Epignomics, Radiogenomics, Imaging Markers Supplemental material is available for this article. © RSNA, 2023.


Asunto(s)
Neoplasias , Humanos , Neoplasias/diagnóstico por imagen , Neoplasias/genética , Neoplasias/terapia , Genómica/métodos , Fenotipo , Radiólogos , Biomarcadores
19.
JAMA Netw Open ; 6(11): e2341191, 2023 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-37921773

RESUMEN

This cross-sectional study assesses the association between political ideology and trust in government health agencies for cancer information.


Asunto(s)
Neoplasias , Confianza , Humanos , Gobierno , Agencias Gubernamentales , Neoplasias/terapia
20.
Support Care Cancer ; 31(12): 665, 2023 Nov 03.
Artículo en Inglés | MEDLINE | ID: mdl-37921996

RESUMEN

PURPOSE: Recent clinical practice guidelines have recommended ambulatory management of febrile neutropenia in patients with low risk of complications. Although some centers have begun developing management protocols for these patients, there appears to be a certain reluctance to implement them in clinical practice. Our aim is to evaluate the strengths and weaknesses of this strategy according to available evidence and to propose new lines of research. METHODS: Systematic review using a triple aim approach (efficacy, cost-effectiveness, and quality of life), drawing from literature in MEDLINE (PubMed), Embase, and Cochrane Library databases. The review includes studies that assess ambulatory management for efficacy, cost-efficiency, and quality of life. RESULTS: The search yielded 27 articles that met our inclusion criteria. CONCLUSION: In conclusion, based on current evidence, ambulatory management of febrile neutropenia is safe, more cost-effective than inpatient care, and capable of improving quality of life in oncological patients with this complication. Ambulatory care seems to be an effective alternative to hospitalization in these patients.


Asunto(s)
Neutropenia Febril , Neoplasias , Humanos , Adulto , Neoplasias/complicaciones , Neoplasias/terapia , Fiebre/etiología , Fiebre/terapia , Calidad de Vida , Hospitalización , Neutropenia Febril/terapia , Neutropenia Febril/complicaciones
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...